Delivery Order SPE2DB22D1200-SPE2DB25FN3TE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order valued at $8,536.19 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a prescription nasal spray used for acute seizure management in patients with epilepsy and represents part of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, valued at $13,527.84 on August 12, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.07 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, effective July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute seizure management, reflecting the pharmaceutical supply needs of...
- The Defense Logistics Agency awarded a delivery order valued at $6,761.00 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved nasal spray formulation of diazepam used for acute seizure management, making this procurement part of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, a medication used for acute seizure treatment. This competitive, firm fixed-price delivery order, valued at $4,685.26, was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio. Performance will occur at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,580.78 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is an FDA-approved nasal spray formulation of diazepam used for acute seizure management, representing a specialty...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3TEDelivery Order
The Defense Logistics Agency awarded a $1,747.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract was issued on August 11, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Valtoco is a prescription nasal spray medication used for acute seizure management, representing a specialized pharmaceutical product within the federal medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen's position as a prime pharmaceutical vendor reflects its established capability to meet federal procurement requirements for critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/11/25 |